Tempest Therapeutics Inc. (TPST)
Tempest Therapeutics Statistics
Share Statistics
Tempest Therapeutics has 3.52M shares outstanding. The number of shares has increased by 96.43% in one year.
Shares Outstanding | 3.52M |
Shares Change (YoY) | 96.43% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 26.28% |
Shares Floating | 3.2M |
Failed to Deliver (FTD) Shares | 4.99K |
FTD / Avg. Volume | 8.06% |
Short Selling Information
The latest short interest is 1.63M, so 46.42% of the outstanding shares have been sold short.
Short Interest | 1.63M |
Short % of Shares Out | 46.42% |
Short % of Float | 50.34% |
Short Ratio (days to cover) | 3.54 |
Valuation Ratios
The PE ratio is -7.23 and the forward PE ratio is -4.63. Tempest Therapeutics's PEG ratio is 0.34.
PE Ratio | -7.23 |
Forward PE | -4.63 |
PS Ratio | 0 |
Forward PS | 0.2 |
PB Ratio | 15.83 |
P/FCF Ratio | -9.05 |
PEG Ratio | 0.34 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tempest Therapeutics.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.8.
Current Ratio | 2.21 |
Quick Ratio | 2.21 |
Debt / Equity | 0.8 |
Debt / EBITDA | - |
Debt / FCF | -0.46 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-1.74M |
Employee Count | 24 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | -41.84M |
Effective Tax Rate | 100% |
Stock Price Statistics
The stock price has increased by 130.52% in the last 52 weeks. The beta is -2.28, so Tempest Therapeutics's price volatility has been lower than the market average.
Beta | -2.28 |
52-Week Price Change | 130.52% |
50-Day Moving Average | 9.81 |
200-Day Moving Average | 13.1 |
Relative Strength Index (RSI) | 45.4 |
Average Volume (20 Days) | 61.85K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | 0 |
Net Income | -41.84M |
EBITDA | 0 |
EBIT | n/a |
Earnings Per Share (EPS) | -1.5 |
Balance Sheet
The company has 30.27M in cash and 15.37M in debt, giving a net cash position of 14.9M.
Cash & Cash Equivalents | 30.27M |
Total Debt | 15.37M |
Net Cash | 14.9M |
Retained Earnings | -207.11M |
Total Assets | 41.49M |
Working Capital | 17.25M |
Cash Flow
In the last 12 months, operating cash flow was -33.03M and capital expenditures -435K, giving a free cash flow of -33.46M.
Operating Cash Flow | -33.03M |
Capital Expenditures | -435K |
Free Cash Flow | -33.46M |
FCF Per Share | -1.2 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TPST does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for TPST is $16, which is 101.8% higher than the current price. The consensus rating is "Hold".
Price Target | $16 |
Price Target Difference | 101.8% |
Analyst Consensus | Hold |
Analyst Count | 3 |
Stock Splits
The last stock split was on Apr 9, 2025. It was a backward split with a ratio of 1:13.
Last Split Date | Apr 9, 2025 |
Split Type | backward |
Split Ratio | 1:13 |
Scores
Altman Z-Score | -8.99 |
Piotroski F-Score | 3 |